Literature DB >> 32946290

The Interplay of the Genetic Architecture, Aging, and Environmental Factors in the Pathogenesis of Idiopathic Pulmonary Fibrosis.

Annie Pardo1, Moisés Selman2.   

Abstract

Idiopathic pulmonary fibrosis (IPF) is a chronic fibrosing lung disease of indeterminate etiology and limited therapeutic options. The initiation, development and progression of IPF are influenced by genetic predisposition, aging, and host and environmental factors, but the magnitude of the contribution of each of them, and the sequence of the pathogenic events are uncertain. Current evidence indicates that accumulated environmental exposures in a genetically predisposed individual usually over 60 years, lead to phenotypic and functional alterations of the lung epithelium. Aberrant activation of epithelial cells results, through a complex release of numerous mediators, in the local expansion of peculiar subsets of aggressive fibroblasts and myofibroblasts, which are crucial effector cells of the fibrotic remodeling and loss of the normal lung architecture and function. Progressive increase of the mechanical stiffness activates cell autonomous and matrix-dependent processes contributing to the perpetuation of the fibrotic response. This perspective provides an integral overview of the major risk factors underpinning the pathogenesis of IPF including gene variants, aging alterations, environmental/host risk factors and epigenetic reprogramming.

Entities:  

Keywords:  lung fibrosis, aging, genetic predisposition, gene variants, smoking, epigenetic reprogramming

Year:  2020        PMID: 32946290     DOI: 10.1165/rcmb.2020-0373PS

Source DB:  PubMed          Journal:  Am J Respir Cell Mol Biol        ISSN: 1044-1549            Impact factor:   6.914


  12 in total

1.  ASK1 Regulates Bleomycin-induced Pulmonary Fibrosis.

Authors:  Samuel S Valenca; Brittany E Dong; Elizabeth M Gordon; Ramon C Sun; Christopher M Waters
Journal:  Am J Respir Cell Mol Biol       Date:  2022-05       Impact factor: 7.748

Review 2.  COVID-19 and pulmonary fibrosis: A potential role for lung epithelial cells and fibroblasts.

Authors:  Alison E John; Chitra Joseph; Gisli Jenkins; Amanda L Tatler
Journal:  Immunol Rev       Date:  2021-05-24       Impact factor: 10.983

Review 3.  Epigenetic Mechanisms in Parenchymal Lung Diseases: Bystanders or Therapeutic Targets?

Authors:  Edibe Avci; Pouya Sarvari; Rajkumar Savai; Werner Seeger; Soni S Pullamsetti
Journal:  Int J Mol Sci       Date:  2022-01-04       Impact factor: 5.923

Review 4.  Idiopathic Pulmonary Fibrosis: An Update on Pathogenesis.

Authors:  Qianru Mei; Zhe Liu; He Zuo; Zhenhua Yang; Jing Qu
Journal:  Front Pharmacol       Date:  2022-01-19       Impact factor: 5.810

5.  Serum Levels of Mitochondrial Fission- and Fusion-Related Genes of Coal Workers' Pneumoconiosis and Risk Factor Analysis Based on a Generalized Linear Model.

Authors:  Xiao-Yu Li; Jing-Lin Wei; Yong-Xin Xie; Ji Zhao; Li-Ya Ma; Na Zhang; Hui-Fang Yang
Journal:  Appl Bionics Biomech       Date:  2022-04-01       Impact factor: 1.781

6.  Mammalian Neuraminidases in Immune-Mediated Diseases: Mucins and Beyond.

Authors:  Erik P Lillehoj; Irina G Luzina; Sergei P Atamas
Journal:  Front Immunol       Date:  2022-04-11       Impact factor: 8.786

7.  Single Nucleotide Polymorphisms (SNP) and SNP-SNP Interactions of the Surfactant Protein Genes Are Associated With Idiopathic Pulmonary Fibrosis in a Mexican Study Group; Comparison With Hypersensitivity Pneumonitis.

Authors:  Ata Abbasi; Chixiang Chen; Chintan K Gandhi; Rongling Wu; Annie Pardo; Moises Selman; Joanna Floros
Journal:  Front Immunol       Date:  2022-06-02       Impact factor: 8.786

Review 8.  Dissecting the Role of Mesenchymal Stem Cells in Idiopathic Pulmonary Fibrosis: Cause or Solution.

Authors:  Anna Valeria Samarelli; Roberto Tonelli; Irene Heijink; Aina Martin Medina; Alessandro Marchioni; Giulia Bruzzi; Ivana Castaniere; Dario Andrisani; Filippo Gozzi; Linda Manicardi; Antonio Moretti; Stefania Cerri; Riccardo Fantini; Luca Tabbì; Chiara Nani; Ilenia Mastrolia; Daniel J Weiss; Massimo Dominici; Enrico Clini
Journal:  Front Pharmacol       Date:  2021-07-05       Impact factor: 5.810

9.  Idiopathic pulmonary fibrosis and diabetes mellitus: a meta-analysis and systematic review.

Authors:  Le Bai; Li Zhang; Tingyu Pan; Wei Wang; Dian Wang; Cassidy Turner; Xianmei Zhou; Hailang He
Journal:  Respir Res       Date:  2021-06-08

Review 10.  Genetics and animal models of familial pulmonary fibrosis.

Authors:  Koji Yasutomo
Journal:  Int Immunol       Date:  2021-11-25       Impact factor: 4.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.